Clinical trial
Efficacy of Lansoprazole in Chronic Post Nasal Drip
NCT00335283 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00335283 |
|---|---|
| Title | Efficacy of Lansoprazole in Chronic Post Nasal Drip |
| Official title | Randomized Placebo-Controlled Trial of BID Lansoprazole in Isolated Chronic Post Nasal Drip |
| Acronym | PND |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | TAP Pharmaceutical Products Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Larynx Disease |
| Intervention type | Drug, Procedure |
| Interventions | Lansoprazole Tablet, PH and impedence testing, manometry, lansoprazole, placebo |
| Enrollment | 75 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 9, 2006 |
| Last update posted | Aug 21, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: